Preferred Label : hypercholesterolemia;

MeSH definition : A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.;

MeSH synonym : hypercholesterolemias; hypercholesteremia; hypercholesteremias; elevated cholesterol; High Cholesterol Levels; Cholesterol Level, High; Cholesterol Levels, High; High Cholesterol Level; Level, High Cholesterol; Levels, High Cholesterol; Cholesterol, Elevated; Cholesterols, Elevated; Elevated Cholesterols;

Wikipedia link : https://en.wikipedia.org/wiki/Hypercholesterolemia;

CISMeF synonym (patient and slang languages) : faire du cholestérol;

Details


Main resources

You can consult :

A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.

https://www.has-sante.fr/jcms/p_3506440/fr/repatha-evolocumab-hypercholesterolemie
2024
false
false
false
France
evaluation of the transparency committee
repatha
Hypercholesterolemia
hypercholesterolemia
evolocumab
Evolocumab
evolocumab
hypercholesterolemia, nos

---
https://www.ameli.fr/assure/sante/themes/trop-de-cholesterol-et-ou-de-triglycerides-dans-le-sang
2018
false
false
false
false
France
French
popular works
cholesterol
cholesterol
triglycerides
hypercholesterolemia
neutral fat
blood
Cholesterol
atherosclerosis

---
https://dumas.ccsd.cnrs.fr/dumas-01948467/document
2018
France
dissertations, academic
hypercholesterolemia, nos
health
Acrogeria
Stress fracture
hypercholesterolemia
primary prevention
Physicians
general practitioners
Hypercholesterolemia
principal
patient care management

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=FR&Expert=477811
2017
false
false
false
France
French
scientific and technical information
hypercholesterolemia, nos
hypercholesterolemia
rare

---
http://www.has-sante.fr/portail/jcms/c_2039802/fr/principales-dyslipidemies-strategies-de-prise-en-charge
2017
false
false
false
France
French
scientific and technical information
cardiovascular risk
risk assessment
cardiovascular diseases
primary prevention
secondary prevention
practice guidelines as topic
aged
hypercholesterolemia
hypercholesterolemia
life style
hydroxymethylglutaryl-coa reductase inhibitors
cholesterol, LDL

---
http://www.extenso.org/article/consommer-un-pois-sec-par-jour-diminue-le-taux-de-cholesterol/
2017
false
false
false
France
French
popular works
daytime
consumption
cholesterol
decreased
cholesterol
dry
abate
Pisum sativum
hypercholesterolemia
economics
temefos

---
https://www.franceculture.fr/emissions/la-methode-scientifique/la-methode-scientifique-lundi-18-decembre-2017
2017
false
false
false
France
French
radio broadcast
disease
disease, nos
cholesterol
cholesterol
hypercholesterolemia
disease

---
https://www.revmed.ch/RMS/2017/RMS-N-558/Inhibiteurs-de-la-PCSK9
2017
false
false
false
Switzerland
French
journal article
Proprotein Convertase 9
Proprotein Convertase 9
anticholesteremic agents
anticholesteremic agents
cardiovascular diseases
risk factors
cholesterol, LDL
At increased risk for cardiovascular event (finding)
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
Proprotein Convertase 9
mutation
alirocumab
evolocumab
PCSK9 protein, human
bococizumab
comparative effectiveness research
high serum cholesterol, familial
antibodies, monoclonal
serine endopeptidases
proprotein convertases
antibodies, monoclonal, humanized
hyperlipoproteinemia type ii

---
https://www.revmed.ch/RMS/2016/RMS-N-508/Inhibiteurs-de-la-PCSK9-un-nouveau-traitement-pour-l-hypercholesterolemie
2016
false
false
false
Switzerland
French
journal article
therapeutics
new
hypercholesterolemia, nos
hypercholesterolemia

---
https://dumas.ccsd.cnrs.fr/dumas-01386458
2016
false
false
false
France
French
dissertations, academic
general practice
Healthy Lifestyle
hypercholesterolemia
dietetics
general practitioners
patient education as topic

---
http://www.rfi.fr/emission/20160622-le-cholesterol-maladies-cardiovasculaires-medecins-sans-frontieres-je-ne-suis-pas-johnny
2016
false
false
false
France
French
radio broadcast
hypercholesterolemia
diet

---
http://www.prescrire.org/Fr/3/31/51924/0/NewsDetails.aspx
2016
false
false
false
France
French
french abstract
evolocumab
hypercholesterolemia
alirocumab
antibodies, monoclonal

---
http://www.revmed.ch/RMS/2015/RMS-N-496/Prise-en-charge-des-facteurs-de-risque-des-maladies-cardiovasculaires-qu-est-ce-qui-a-vraiment-change-en-15-ans
2015
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
risk factors
practice guidelines as topic
hypercholesterolemia
hypertension
diabetes mellitus, type 2
hypertension
cardiovascular diseases

---
http://www.rfi.fr/emission/20151126-cholesterol-maladies-cardiovasculaires-sante
2015
false
false
false
France
French
radio broadcast
diet
hypercholesterolemia

---
https://medicalforum.ch/fr/detail/doi/fms.2014.01905/
2014
false
Switzerland
French
cardiovascular diseases
journal article
practice guideline
cholesterol, LDL
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
risk
cardiovascular risk

---
http://www.cochrane.org/fr/CD009518
2013
United Kingdom
France
French
review of literature
hypercholesterolemia
adult
isoflavones
treatment outcome
french abstract

---
http://www.lefaitmedical.ch/fr/articles/preventions-primaire-et-secondaire-de-l-hypercholesterolemie-76-510
2013
Switzerland
French
hypercholesterolemia
journal article
cardiovascular diseases

---
http://www.atoute.org/cgi-bin/dcforum/dcboard.cgi?az=list&forum=DCForumID17&conf=DCConfID6
France
French
cardiovascular risk
forum and mailing list for patients
hypercholesterolemia
hypertriglyceridemia
cardiovascular diseases
risk factors

---
http://www.rfi.fr/emission/20130312-1-statines-le-cholesterol
http://www.rfi.fr/emission/20130312-2-statines-le-cholesterol
2012
France
French
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
radio broadcast
popular works

---
https://www.revmed.ch/RMS/2012/RMS-331/Depistage-et-prise-en-charge-des-dyslipidemies-familiales-point-de-vue-du-pediatre-et-de-l-interniste-generaliste
2012
Switzerland
French
journal article
hyperlipidemias
hypercholesterolemia
hyperlipidemias
hypercholesterolemia
mass screening
hyperlipidemias
hypercholesterolemia

---
https://www.has-sante.fr/jcms/r_1439693
2012
true
France
French
Atorvastatin
Rosuvastatin Calcium
cardiovascular diseases
Cost-Benefit analysis
hydroxymethylglutaryl-coa reductase inhibitors
hmg coa reductase inhibitors
risk factors
cholesterol, LDL
hypercholesterolemia
simvastatin
anticholesteremic agents
pravastatin
treatment outcome
fatty acids, monounsaturated
indoles
guidelines for drug use
Fluvastatin

---
http://www.cochrane.org/fr/CD008305
2011
United Kingdom
France
French
meta-analysis
drugs, chinese herbal
hypercholesterolemia
phytotherapy
randomized controlled trials as topic
treatment outcome
french abstract

---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=209902
2011
France
scientific and technical information
hypercholesterolemia
cholesterol
mixed function oxygenases

---
http://www.cochrane.org/fr/CD007957
2011
United Kingdom
France
French
review of literature
hypercholesterolemia
treatment outcome
diet, fat-restricted
french abstract

---
https://medicalforum.ch/fr/detail/doi/fms.2011.07559/
2011
false
Switzerland
French
journal article
hypercholesterolemia
hydroxymethylglutaryl-coa reductase inhibitors
cholesterol, LDL
hypercholesterolemia
hydroxymethylglutaryl-coa reductase inhibitors

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-07/synthese_efficacite_et_efficience_des_hypolipemiants_-_une_analyse_centree_sur_les_statines.pdf
http://www.has-sante.fr/portail/jcms/c_968814/argumentaire-efficacite-et-efficience-des-hypolipemiants-une-analyse-centree-sur-les-statines
http://www.has-sante.fr/portail/jcms/c_968815/annexes-efficacite-et-efficience-des-hypolipemiants-une-analyse-centree-sur-les-statines
http://www.has-sante.fr/portail/jcms/c_969195/efficacite-et-efficience-des-hypolipemiants-une-analyse-centree-sur-les-statines
http://www.has-sante.fr/portail/jcms/c_968816/efficacite-et-efficience-des-hypolipemiants-une-analyse-centree-sur-les-statines
2010
true
France
French
costs and cost analysis
health technology assessment
hydroxymethylglutaryl-coa reductase inhibitors
hydroxymethylglutaryl-coa reductase inhibitors
cardiovascular diseases
hydroxymethylglutaryl-coa reductase inhibitors
Cost-Benefit analysis
treatment outcome
hypercholesterolemia
drug evaluation
economic evaluation
comparative study

---
http://www.cochrane.org/fr/CD001366
2009
false
true
false
United Kingdom
France
nutritionists
general practitioners
treatment outcome
general practice
review of literature
french abstract
hypercholesterolemia

---
http://www.cochrane.org/fr/CD004289
2009
false
true
false
France
United Kingdom
hypercholesterolemia
treatment outcome
review of literature
french abstract
dialysis
hydroxymethylglutaryl-coa reductase inhibitors

---
http://www.extenso.org/sante/detail.php/f/1650
2008
Canada
French
phytosterols
hypercholesterolemia
popular works

---
http://www.anses.fr/sites/default/files/documents/NUT2006sa0337.pdf
2008
false
true
false
France
evaluation studies
hypercholesterolemia
cholesterol
fats

---
http://www.nhs.uk/translationfrench/Documents/Cholesterol_French_FINAL.pdf
2008
United Kingdom
French
cholesterol
hypercholesterolemia
popular works

---
http://pap-pediatrie.fr/biologieg%C3%A9n%C3%A9tique/28/hypercholest%C3%A9rol%C3%A9mie-de-lenfant
2008
false
France
French
algorithms
scientific and technical information
hypercholesterolemia
child

---
http://www.anses.fr/sites/default/files/documents/NUT2006sa0300.pdf
2007
France
French
cholesterol, LDL
hypercholesterolemia
fatty acids, Omega-6
fatty acids, Omega-3
evaluation studies

---
http://www.has-sante.fr/portail/display.jsp?id=c_498794
2006
false
France
French
Primary hypercholesterolemia (disorder)
Ezetimibe, Simvastatin Drug Combination
Ezetimibe
mixed dyslipidemia
hypercholesterolemia
anticholesteremic agents
hydroxymethylglutaryl-coa reductase inhibitors
muscles
rhabdomyolysis
anticholesteremic agents
drug therapy, combination
simvastatin and ezetimibe
ezetimibe
guidelines for drug use
algorithms

---
http://revmed.ch/RMS/2005/RMS-39/30753
2005
Switzerland
French
Primary hypercholesterolemia (disorder)
aged, 80 and over
age factors
cardiovascular diseases
hypercholesterolemia
cardiovascular diseases
risk factors
aged
hydroxymethylglutaryl-coa reductase inhibitors
hypercholesterolemia
hmg coa reductase inhibitors
journal article
drug information

---
https://rmlg.uliege.be/article/1307
2005
Belgium
French
hypercholesterolemia
hypercholesterolemia
hypercholesterolemia
internet
databases, bibliographic
Evidence-Based medicine
journal article

---
http://www.diffusion.ens.fr/index.php?res=conf&idconf=749
2004
audiovisual material
fatty acids, essential
hypercholesterolemia
cholesterol

---
http://www.john-libbey-eurotext.fr/fr/revues/medecine/stv/e-docs/00/04/09/38/resume.md?type=text.html
2004
France
French
English
coronary artery disease
heart transplantation
coronary artery disease
coronary artery disease
risk factors
anticholesteremic agents
coronary artery disease
pravastatin
hydroxymethylglutaryl-coa reductase inhibitors
cyclosporine
cyclosporine
immunosuppressive agents
immunosuppressive agents
drug interactions
hypercholesterolemia
graft survival
hypercholesterolemia
coronary artery disease
coronary artery disease
signs and symptoms
angioplasty, balloon, coronary
treatment outcome
survival rate
hydroxymethylglutaryl-coa reductase inhibitors
continuity of patient care
simvastatin
journal article
french abstract

---
https://www.cadth.ca/sites/default/files/pdf/108_No27_ezetimibe_edrug_f.pdf
2002
false
Canada
French
Ezetimibe
anticholesteremic agents
hypercholesterolemia
clinical trials as topic
ezetimibe
drug evaluation

---
http://www.ulb.ac.be/esp/gras/traiterchol.html
1999
Belgium
French
hypercholesterolemia
guidelines

---
http://www.ulb.ac.be/esp/gras/hyperchol.html
1998
Belgium
French
hypercholesterolemia
guidelines

---
Nous contacter.
25/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.